Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 81% ± 24% | |
peripheral blood | 21 studies | 90% ± 12% | |
brain | 21 studies | 56% ± 22% | |
intestine | 14 studies | 88% ± 17% | |
eye | 12 studies | 70% ± 29% | |
liver | 9 studies | 69% ± 25% | |
kidney | 9 studies | 85% ± 21% | |
bone marrow | 7 studies | 68% ± 30% | |
lymph node | 7 studies | 94% ± 4% | |
heart | 6 studies | 41% ± 18% | |
uterus | 6 studies | 87% ± 14% | |
pancreas | 5 studies | 85% ± 20% | |
placenta | 5 studies | 72% ± 34% | |
prostate | 5 studies | 74% ± 32% | |
adipose | 4 studies | 59% ± 29% | |
esophagus | 4 studies | 65% ± 27% | |
skin | 4 studies | 79% ± 22% | |
breast | 4 studies | 97% ± 3% | |
ovary | 3 studies | 85% ± 15% | |
adrenal gland | 3 studies | 82% ± 21% | |
stomach | 3 studies | 63% ± 18% | |
thymus | 3 studies | 77% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 21648.48 | 180 / 180 | 100% | 2316.26 | 430 / 430 |
stomach | 100% | 22886.26 | 359 / 359 | 98% | 560.34 | 280 / 286 |
esophagus | 97% | 28617.60 | 1406 / 1445 | 100% | 488.67 | 183 / 183 |
intestine | 100% | 30984.45 | 964 / 966 | 85% | 398.96 | 450 / 527 |
kidney | 100% | 38018.66 | 89 / 89 | 84% | 146.77 | 761 / 901 |
bladder | 100% | 35375.29 | 21 / 21 | 83% | 206.19 | 418 / 504 |
thymus | 99% | 24332.38 | 646 / 653 | 84% | 175.42 | 508 / 605 |
lung | 100% | 46384.28 | 576 / 578 | 83% | 190.49 | 958 / 1155 |
breast | 100% | 41466.38 | 459 / 459 | 79% | 125.14 | 886 / 1118 |
brain | 95% | 26386.28 | 2515 / 2642 | 81% | 159.70 | 568 / 705 |
skin | 91% | 33675.19 | 1640 / 1809 | 84% | 153.74 | 396 / 472 |
pancreas | 96% | 15809.72 | 314 / 328 | 79% | 140.01 | 140 / 178 |
uterus | 99% | 22793.56 | 169 / 170 | 74% | 129.31 | 338 / 459 |
liver | 82% | 12142.15 | 186 / 226 | 82% | 138.61 | 331 / 406 |
prostate | 99% | 19771.86 | 243 / 245 | 64% | 75.90 | 319 / 502 |
adrenal gland | 100% | 39113.64 | 258 / 258 | 57% | 68.77 | 131 / 230 |
adipose | 100% | 48253.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 23342.16 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.29 | 1 / 1 |
peripheral blood | 100% | 72627.47 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 33460.73 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 259.85 | 78 / 80 |
muscle | 95% | 20967.51 | 763 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 22696.09 | 808 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 232.78 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 67% | 77.79 | 30 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0006880 | Biological process | intracellular sequestering of iron ion |
GO_0110076 | Biological process | negative regulation of ferroptosis |
GO_0006826 | Biological process | iron ion transport |
GO_0006955 | Biological process | immune response |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0044754 | Cellular component | autolysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0070288 | Cellular component | ferritin complex |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004322 | Molecular function | ferroxidase activity |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005506 | Molecular function | iron ion binding |
GO_0008199 | Molecular function | ferric iron binding |
GO_0140315 | Molecular function | iron ion sequestering activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FTH1 |
Protein name | Ferritin heavy chain Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed] Ferritin |
Synonyms | hCG_1776129 PIG15 FTH OK/SW-cl.84 FTHL6 |
Description | FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Has ferroxidase activity . Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation . Also plays a role in delivery of iron to cells (By similarity). Mediates iron uptake in capsule cells of the developing kidney (By similarity). . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . FUNCTION: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. . |
Accessions | E9PPQ4 ENST00000273550.12 P02794 ENST00000534180.1 E9PQR3 Q6NS36 G3V192 Q6NZ44 ENST00000529631.5 ENST00000532829.5 ENST00000526640.5 E9PK45 ENST00000530019.5 ENST00000532601.1 G3V1D1 E9PRK8 ENST00000529548.1 A9JQE1 ENST00000529191.5 E9PKY7 E9PKM5 ENST00000620041.5 |